Si-Bone (SIBN) Net Cash Flow Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -562.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -564.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 76.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -31.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -394.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 57.36% |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn | -247.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -247.03% |
| Dec 31, 2025 | 190.29% |
| Sep 30, 2025 | -281.71% |
| Jun 30, 2025 | -10.60% |
| Mar 31, 2025 | 620.29% |
| Dec 31, 2024 | 126.70% |
| Sep 30, 2024 | 107.39% |
| Jun 30, 2024 | -107.27% |
| Mar 31, 2024 | -151.93% |
| Dec 31, 2023 | -239.85% |
| Sep 30, 2023 | -2,579.62% |
| Jun 30, 2023 | 3,432.60% |
| Mar 31, 2023 | 105.99% |
| Dec 31, 2022 | -262.90% |
| Sep 30, 2022 | -80.62% |
| Jun 30, 2022 | -124.77% |
| Mar 31, 2022 | -126.39% |
| Dec 31, 2021 | 238.15% |
| Sep 30, 2021 | 216.20% |
| Jun 30, 2021 | 855.40% |
| Mar 31, 2021 | -127.79% |
| Dec 31, 2020 | -20.72% |
| Sep 30, 2020 | -969.44% |
| Jun 30, 2020 | -26.39% |
| Mar 31, 2020 | 556.87% |
| Dec 31, 2019 | -119.77% |
| Sep 30, 2019 | 154.24% |
| Jun 30, 2019 | 29.09% |
| Mar 31, 2019 | -171.34% |
| Dec 31, 2018 | 153.13% |